M&A Deal Summary

Wellbeing Digital Sciences Acquires Integrated Rehab and Performance

On April 23, 2021, Wellbeing Digital Sciences acquired consumer services company Integrated Rehab and Performance for 1M USD

Acquisition Highlights
  • This is Wellbeing Digital Sciences’ 1st transaction in the Consumer Services sector.
  • This is Wellbeing Digital Sciences’ 2nd largest (disclosed) transaction.
  • This is Wellbeing Digital Sciences’ 1st transaction in Canada.
  • This is Wellbeing Digital Sciences’ 1st transaction in British Columbia.

M&A Deal Summary

Date 2021-04-23
Target Integrated Rehab and Performance
Sector Consumer Services
Buyer(s) Wellbeing Digital Sciences
Deal Type Add-on Acquisition
Deal Value 1M USD

Target

Integrated Rehab and Performance

Victoria, British Columbia, Canada
Integrated Rehab and Performance operates multidisciplinary physical therapy clinic exclusively for patients who are past or present personnel of the Canadian Armed Forces or Royal Canadian Mounted Police, and first responders (e.g., firefighters, law enforcement officers, paramedics, EMTs, etc.). Integrated Rehab and Performance was formed in 2018 and is based in Victoria, British Columbia.

Search 215,029 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Wellbeing Digital Sciences

Vancouver, British Columbia, Canada

Category Company
Founded 2017
Sector Business Services
DESCRIPTION

Wellbeing Digital Sciences is a single-purpose company focused in mental health. Wellbeing Digital Sciences was founded in 2017 and is headquartered in Vancouver, British Columbia.


DEAL STATS #
Overall 1 of 2
Sector: Consumer Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: British Columbia M&A 1 of 1
Country: Canada M&A 1 of 2
Year: 2021 M&A 1 of 2
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-27 KGK Science

London, Ontario, Canada

Founded in 1997, KGK Science is a contract research organization based in London, Ontario that primarily provides high-quality clinical research trials with a focus on the nutraceutical, cannabis, and emerging psychedelic industries. For over 23 years, the business has successfully helped hundreds of companies with custom-designed clinical trials and claim substantiation strategies to move products into global markets. KGK’s other existing service lines include expert regulatory support and compliance solutions, participant recruitment, research support services, and consulting services. On an approximate basis, the business to date has produced 150 publications, executed over 400 clinical trials across more than 40 indications, amassed 25,000 participants in its database, and collected 10 million data points.

Buy $17M